Diphtheria and tetanus toxoids and acellular pertussis vaccine (DTaP) - Doses at 2, 4, 6, and 15 to 18 months and again at 4 to 6 years of age Tetanus and diphtheria toxoids and pertussis vaccine (DTaP) - One dose at 11 to 12 years of age
Tetanus and diphtheria (Td) booster - One dose every 10 years following DTaP
Haemophilus influenza type b (Hib) - Doses at 2, 4, 6, and at 12 to 15 months
Rotavirus (RV) oral vaccine - Available in two formulations
RotaTeq requires three doses beginning at 6 weeks of age, with subsequent doses 4 to 10 weeks apart. RotaTeq vaccination should be completed before 32 weeks of age.Vaccination should not be initiated for infants 15 weeks of age or older.
Rotarix requires 2 doses beginning at 6 weeks of age with the next dose4weeks later. All doses should be completed by 8 months of age. Inactivated poliovirus vaccine (IPV)-Doses at 2, 4, and 6 to 18 months and again at 4 to 6 years
Measles, mumps, and rubella vaccine (MMR) - Doses at 12 to 15 months and at 4 to 6 years
Varicella vaccine - One dose at 12 to 15 months and again at 4 to 6 years or 2 doses administered 4 weeks apart if administered after age 13
Pneumococcal conjugate vaccine (PCV) - Doses at 2, 4, 6, and 12 to 15 months
Hepatitis A (Hep A) - Two doses 6 months apart after 12 months of age
Hepatitis B (Hep B) - Within 12 hr after birth with additional doses at 1 to 2 months and 6 to 18 months of age
Seasonal influenza vaccine - Annually beginning at 6 months, the trivalent inactivated influenza vaccine (TIV) should be given. Starting at 2 years of age, the live attenuated influenza vaccine (LAIV) (nasal spray) should be used. October through November is the ideal time, but December is acceptable.
Meningococcal vaccine (MCV4) - One dose at 11 to 12 years of age (earlier if specific risk factors are present)
Human Papilloma Virus (HPV2, HPV4) - Three doses should be given over a 6-month interval for females at 11 to 12 years of age (minimum age is 9 years). The second dose should be administered 2 months after the first dose, and the third dose should be administered 6 months after the first dose. HPV4 may be given to males starting at age 9 years of age.